In addition, ANGPTL2 expression being sensitive to hypoxia [11], epigenetic DNA methylation of ANGPTL2 promoter occurs in hypoxic tumour cells, leading to an increase in ANGPTL2 expression ultimately reinforcing the inflammatory response and the aggressive cancer cell phenotype [3]. This evidence concerns the gene ANGPTL2 and cancer.